NURECA LIMITED (NURECA) financials

NURECA LIMITED (NURECA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.[1]

Market Cap: ₹318Cr.
Current Price: ₹333
Stock P/E: 120
ROE: 0.16%
ROCE: 2.07%
Book Value: ₹192
Dividend Yield: 0.00%
52W High / Low: ₹376/200

In Sep 2026, NURECA LIMITED (NURECA) reported sales ₹58.60 Cr and net profit ₹3.62 Cr.

Annual TTM: sales ₹174 Cr, net profit ₹3 Cr.

Shareholding: Promoters 70.68% (Sep 2026), FIIs 0.22% (Sep 2026), DIIs 0.24% (Sep 2026), Public 28.85% (Sep 2026), No. of Shareholders 31,719% (Sep 2026).

NURECA quarterly results (₹ Cr.)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	27.21	31.75	34.32	37.84	39.64	35.41	40.40	58.60
Expenses	31.95	31.19	35.40	35.22	37.25	41.95	37.95	54.05
Operating Profit	-4.74	0.56	-1.08	2.62	2.39	-6.54	2.45	4.55
OPM %	-17.42%	1.76%	-3.15%	6.92%	6.03%	-18.47%	6.06%	7.76%
Other Income	1.52	2.00	2.59	2.38	2.29	1.06	1.92	1.42
Interest	0.14	0.59	0.20	0.41	0.18	0.24	0.18	0.22
Depreciation	0.49	0.48	0.48	0.48	0.46	0.43	0.57	0.76
Profit before tax	-3.85	1.49	0.83	4.11	4.04	-6.15	3.62	4.99
Tax %	-14.55%	-38.93%	33.73%	23.60%	20.30%	7.80%	32.87%	27.45%
Net Profit	-3.29	2.07	0.55	3.14	3.23	-6.63	2.43	3.62
EPS in Rs	-3.29	2.07	0.55	3.14	3.39	-6.95	2.55	3.79
Raw PDF	—	—	—	—	—	—	—	—

NURECA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	99	213	256	112	95	115	147	174
Expenses	90	152	200	127	106	124	150	171
Operating Profit	10	62	56	-15	-11	-10	-3	3
OPM %	10%	29%	22%	-14%	-12%	-8%	-1.8%	1.6%
Other Income	0	3	8	7	11	13	8	7
Interest	1	2	1	0	0	1	1	1
Depreciation	0	0	1	2	2	2	2	2
Profit before tax	9	62	61	-11	-3	-0	3	6
Tax %	26%	26%	26%	-23%	-25%	46%	90%	—
Net Profit	6	47	45	-8	-2	-1	0	3
EPS in Rs	641.00	46.53	45.31	-8.42	-2.44	-0.67	0.31	2.78
Dividend Payout %	0%	4%	7%	0%	0%	0%	0%	—

NURECA balance sheet (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
Equity Capital	0.01	10	10	10	10	10	10	10
Reserves	15	153	194	185	183	182	168	174
Borrowings	10	4	4	3	2	4	2	7
Other Liabilities	9	19	11	8	9	10	14	31
Total Liabilities	34	186	220	207	204	206	194	220
Fixed Assets	1	3	10	8	6	8	12	17
CWIP	0	0	0	0	0	0	0	5
Investments	0	1	34	62	97	4	4	6
Other Assets	33	181	175	136	101	194	177	192
Total Assets	34	186	220	207	204	206	194	220

NURECA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	—	-8	35	2	12	-3	-19	0
Cash from Investing Activity	—	-0	-110	-3	-18	18	9	16
Cash from Financing Activity	—	8	92	-7	-2	-1	-1	-19
Net Cash Flow	—	-0	17	-9	-8	14	-11	-2
Free Cash Flow	—	-8	35	-4	12	-4	-23	-5
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	—	-81%	81%	35%	-107%	40%	183%	4%

NURECA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	64.06%	64.30%	64.33%	64.97%	64.97%	68.09%	68.09%	70.68%
FIIs	0.36%	1.07%	0.07%	0.07%	0.08%	0.28%	0.11%	0.22%
DIIs	0.04%	0.04%	0.04%	0.04%	0.04%	0.24%	0.24%	0.24%
Public	35.54%	34.59%	35.56%	34.92%	34.91%	31.39%	31.57%	28.85%
No. of Shareholders	41,314	39,304	38,075	37,468	35,801	34,558	33,979	31,719

NURECA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	65	47	0	4	14	7	14	24
Inventory Days	590	93	135	174	154	156	163	162
Days Payable	849	33	32	13	23	27	26	23
Cash Conversion Cycle	-195	107	103	165	145	136	151	164
Working Capital Days	-45	85	61	109	148	160	145	132
ROCE %	75%	76%	67%	33%	-5%	-1%	0%	2%

NURECAUpdated 23 Oct 2026, 4:09

Nureca Limited

NURECAUpdated 23 Oct 2026, 4:09

Market Cap

₹318Cr.

Current Price

₹333

High / Low

₹376/200

Stock P/E

120

Book Value₹192

Dividend Yield0.00%

ROCE2.07%

ROE0.16%

Face Value₹10.0

About

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Sep 2023	31.35	0.08	30.31	3.21	0.56	3.61	26.87	2.64	2.64
Dec 2023	22.37	0.1	26.8	5.92	0.56	0.83	90.36	0.08	0.08
Mar 2024	19.56	0.17	24.32	-1.25	0.56	-6.74	-34.57	-4.41	-4.41
Jun 2024	23.31	0.13	26.23	5.82	0.61	2.16	44.91	1.2	1.2
Sep 2024	32.37	0.25	35.03	3.21	0.57	-0.27	140.74	-0.65	-0.65
Dec 2024	27.21	0.14	31.95	1.52	0.49	-3.85	-14.55	-3.29	-3.29
Mar 2025	31.75	0.59	31.19	2	0.48	1.49	-38.93	2.07	2.07
Jun 2025	34.32	0.2	35.4	2.59	0.48	0.83	33.73	0.55	0.55
Sep 2025	37.84	0.41	35.22	2.38	0.48	4.11	23.6	3.14	3.14
Dec 2025	39.64	0.18	37.25	2.29	0.46	4.04	20.3	3.23	3.39
Mar 2026	35.41	0.24	41.95	1.06	0.43	-6.15	7.8	-6.63	-6.95
Jun 2026	40.4	0.18	37.95	1.92	0.57	3.62	32.87	2.43	2.55
Sep 2026	58.6	0.22	54.05	1.42	0.76	4.99	27.45	3.62	3.79

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2017 5m	0	0	0	0	0	0	—	0	0
Mar 2018	1	0	1	0	0	0	50	0	2
Mar 2019	1	0	1	0	0	0	33	0	2
Mar 2020	99	1	90	0	0	9	26	6	641
Mar 2021	213	2	152	3	0	62	26	47	46.53
Mar 2022	256	1	200	8	1	61	26	45	45.31
Mar 2023	112	0	127	7	2	-11	-23	-8	-8.42
Mar 2024	95	0	106	11	2	-3	-25	-2	-2.44
Mar 2025	115	1	124	13	2	0	46	-1	-0.67
Mar 2026	147	1	150	8	2	3	90	0	0.31
TTM	174	1	171	7	2	6	—	3	2.78

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	70.68%
FIIs	0.22%
DIIs	0.24%
Public	28.85%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	63.24%	0.07%	0%	36.69%
Mar 2024	63.24%	0.07%	0%	36.69%
Jun 2024	63.24%	0.07%	0%	36.69%
Sep 2024	63.78%	0.69%	0%	35.53%
Dec 2024	64.06%	0.36%	0.04%	35.54%
Mar 2025	64.3%	1.07%	0.04%	34.59%
Jun 2025	64.33%	0.07%	0.04%	35.56%
Sep 2025	64.97%	0.07%	0.04%	34.92%
Dec 2025	64.97%	0.08%	0.04%	34.91%
Mar 2026	68.09%	0.28%	0.24%	31.39%
Jun 2026	68.09%	0.11%	0.24%	31.57%
Sep 2026	70.68%	0.22%	0.24%	28.85%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2017	0.01	0	0	0	0	0	0	0	0	0
Mar 2018	0.01	0	0	0	0	0	0	0	0	0
Mar 2019	0.01	0	0	1	1	0	0	0	1	1
Mar 2020	0.01	15	10	9	34	1	0	0	33	34
Mar 2021	10	153	4	19	186	3	0	1	181	186
Mar 2022	10	194	4	11	220	10	0	34	175	220
Mar 2023	10	185	3	8	207	8	0	62	136	207
Mar 2024	10	183	2	9	204	6	0	97	101	204
Mar 2025	10	182	4	10	206	8	0	4	194	206
Mar 2026	10	168	2	14	194	12	0	4	177	194
Sep 2026	10	174	7	31	220	17	5	6	192	220

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2017	0	0	0	0
Mar 2018	—	—	—	—
Mar 2019	—	—	—	—
Mar 2020	-8	0	8	0
Mar 2021	35	-110	92	17
Mar 2022	2	-3	-7	-9
Mar 2023	12	-18	-2	-8
Mar 2024	-3	18	-1	14
Mar 2025	-19	9	-1	-11
Mar 2026	0	16	-19	-2

Key ratios

Historical financial ratios

Category	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	365	87	65	47	0	4	14	7	14	24
Inventory Days	0	101	590	93	135	174	154	156	163	162
Days Payable	—	233	849	33	32	13	23	27	26	23
Cash Conversion Cycle	365	-45	-195	107	103	165	145	136	151	164
Working Capital Days	182	-12	-45	85	61	109	148	160	145	132
ROCE %	—	100%	75%	76%	67%	33%	-5%	-1%	0%	2%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of NURECA LIMITED (NURECA)?

The reported market capitalisation for NURECA LIMITED (NURECA) is ₹318Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of NURECA?

The current price shown for NURECA LIMITED (NURECA) on Fincrux is ₹333 with a 52-week high/low of ₹376/200.

What is the P/E ratio of NURECA LIMITED (NURECA)?

The stock P/E for NURECA LIMITED (NURECA) is 120 on Fincrux, with ROE at 0.16% and ROCE at 2.07%.

What were NURECA latest quarterly results?

For Sep 2026, NURECA LIMITED (NURECA) reported sales ₹58.60 Cr and net profit ₹3.62 Cr (figures in ₹ crore unless noted).

What are NURECA annual sales and net profit?

For TTM, NURECA LIMITED (NURECA) shows sales of ₹174 Cr and net profit of ₹3 Cr on the Fincrux profit & loss statement.

Who owns NURECA LIMITED (NURECA)?

Latest shareholding for NURECA LIMITED (NURECA) on Fincrux: Promoters 70.68% (Sep 2026), FIIs 0.22% (Sep 2026), DIIs 0.24% (Sep 2026), Public 28.85% (Sep 2026), No. of Shareholders 31,719% (Sep 2026).

Where can I find NURECA LIMITED (NURECA) financials?

NURECA LIMITED (NURECA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show NURECA balance sheet and cash flow?

Yes. The NURECA LIMITED (NURECA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 23 October 2026 at 4:09